Literature DB >> 9124921

MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis.

J Martin1, K Sarai, M Schindler, A van de Loo, M Yoshitake, F Beyersdorf.   

Abstract

Successful weaning from biventricular mechanical support with full recovery of the myocardial function is extremely rare in fulminant myocarditis. We report on our experience with the MEDOS HIA-VAD ventricular assist device. The device worked for 17 days and provided adequate hemodynamics. Despite anticoagulation therapy, we had to change both ventricles because of clot formation on the surface of the outflow tract. After 17 days the myocardial function had recovered and we could remove the assist system.

Entities:  

Mesh：

Year:  1997        PMID： 9124921     DOI： 10.1016/s0003-4975(97)00067-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  4 in total

1.  Biventricular support using a centrifugal pump in a 6 year old with fulminant myocarditis.

Authors:  Hiromu Kehara; Tamaki Takano; Takamitsu Terasaki; Kenji Okada
Journal:  J Artif Organs       Date:  2016-12-01       Impact factor: 1.731

Review 2.  Pediatric ventricular assist devices.

Authors:  Francis Fynn-Thompson; Christopher Almond
Journal:  Pediatr Cardiol       Date:  2007-01-29       Impact factor: 1.655

Review 3.  Diagnosis and treatment of viral myocarditis.

Authors:  Jason C Schultz; Anthony A Hilliard; Leslie T Cooper; Charanjit S Rihal
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

Review 4.  Ventricular Assist Devices and Their Usage as a Bridge to Recovery in Patients With Acute Cardiotoxicity and Cardiomyopathy.

Authors:  Suyeewin Thiha; Chris A Robert; Abdul Rehman Z Zaidi
Journal:  Cureus       Date:  2020-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.